The Chief Transformation Officer

Healthcare has adopted the title faster than it has defined the job. Four organizations using the same two words mean four different things, and the difference is not stylistic. It follows the margin.

By RaeAnn, Founder and Chief Executive Officer, HLTHWORKS

IN THIS ARTICLE

Who actually holds the title today. Why the health plan version has a shorter life than the health system version. What the role owes each part of the enterprise and what it must never absorb. What the 2027 agenda will demand, and the one item on it that no other forecast contains. And a short test for whether your organization has created a mandate or a job description.

A title without a definition

Healthcare has spent four years handing out a title it has not defined. Search the executive rosters of health systems, medical groups, health plans, and third party administrators and you will find Chief Transformation Officers in all of them. Read the position descriptions side by side and you will find almost nothing in common.

One runs revenue cycle and real estate. One runs a value creation plan with a bottom line number attached. One runs clinical operations and quality. One runs the technology roadmap under a title that also contains the word information. Several run a portfolio assembled from whatever the chief executive could not assign anywhere else.

This is not a criticism of the people holding the role. Most of them are among the more capable executives in their organizations, which is precisely why they were given a mandate nobody had written down. It is a criticism of how the role has been created, because a title that means four things means nothing to a board evaluating whether it is working.

The question is not whether your organization needs a Chief Transformation Officer. It is who owns the bottom line target for change, and whether that person can hold their peers to it.

The most useful finding in the research behind this article is an absence. Humana, an organization that has visibly restructured itself over the past decade, does not carry a Chief Transformation Officer on its leadership team. The work is distributed instead. Corporate strategy, mergers and acquisitions, and the design of a new operating model sit with the Chief Strategy and Corporate Development Officer. The technology transformation agenda sits with the Chief Information Officer. Segment leaders carry their own results.

That absence is more instructive than most of the appointments. It demonstrates that the function can exist without the title, which means the reverse is also true. The title can exist without the function, and frequently does.

A NOTE ON WHERE THIS ANALYSIS COMES FROM

I have held this job. At Cotiviti the mandate was aggressive, explicit, and imperative. Recover margin. Redesign the operation. Deliver growth at a rate the existing structure could not produce. It was brutal operational redesign against a hyper growth expectation, and there was no ambiguity in any part of it. The title on the door was General Manager and Executive Vice President.

That is not an unusual arrangement. It is the ordinary one, and it is worth saying that the hardest transformation work in this industry is frequently done without the title, under a number, on a deadline, by people whose business cards say general manager, segment president, chief operating officer, or senior vice president of operations. Which is the first practical conclusion of this article. If a board wants to know whether transformation is owned in its organization, the titles are the least reliable place to start. Find the person carrying the number.

THE DISTINCTION THAT MATTERS

Innovation creates things that did not exist. Transformation makes things that already exist work differently. These require opposite temperaments, opposite time horizons, and opposite relationships to the existing organization. Innovation is generally welcomed because it adds. Transformation is generally resisted because it takes something away from someone who currently has it. An organization that assigns both to one executive has usually decided to fund the first and describe the second.

Who actually holds this title

Three patterns emerge from the current landscape.

ONE. THE TITLE IS USUALLY ATTACHED TO ANOTHER ONE

Among health systems, the pure form is the exception. Published lists of hospital and health system transformation executives are dominated by compound titles: chief innovation and transformation officer, chief strategy and transformation officer, chief information and digital transformation officer. At one academic medical center the role is held by an industrial and operations engineering professor whose work sits at the intersection of engineering and care delivery.

A compound title is not automatically a weak one. It can indicate that transformation was deliberately anchored to an existing power base rather than floated as a new one. But it does tell you where the center of gravity actually sits, and it is rarely the second word.

TWO. BACKGROUNDS CLUSTER IN TWO PLACES

The people appointed come predominantly from operations or from management consulting. Health system appointments often carry a clinical background, physician or nurse, paired with operational leadership. The consulting pathway is explicit in hiring: one large medical group recruits transformation leaders directly from the major strategy and healthcare consulting firms and describes the work as consulting caliber structured thinking applied to operations, physician alignment, and organizational design.

Almost nobody arrives from compliance, from regulatory affairs, or from risk. That absence has consequences, and this article returns to it.

THREE. THE ROLE IS FREQUENTLY A LANDING PLACE

A notable share of appointments follow an acquisition. An executive arrives with the acquired company, the acquiring organization needs to place them at a level that reflects their prior seniority, and transformation is the available slot. Sometimes this produces exactly the right outcome, because an executive from outside carries the independence the role requires. Sometimes it produces a title in search of a mandate.

WHAT THE CONSULTING LITERATURE HAS SAID FOR A DECADE

The established view holds that the transformation leader should own responsibility for delivering the full bottom line target, that the mandate must be defined at the outset rather than discovered, that the executive should be integrated into the leadership team rather than sidelined into a separate unit, that they should be independent of the decisions that created the current position, and that their compensation should be tied to delivery.

Held against that standard, most healthcare appointments satisfy two conditions at best. The condition most often missing is the first one, which is also the only one that makes the role different from a senior program manager.

Four organizations, four different jobs

The variation is not random and it is not a matter of taste. It follows a single organizing fact: the transformation office is always pointed at wherever the margin actually comes from. Because margin arises differently in a health system, a medical group, a health plan, and a third party administrator, the role differs in each. An organization that copies another sector’s version of the job has imported the wrong target.

SETTING	WHERE MARGIN COMES FROM	WHAT THE ROLE THEREFORE OWNS	LIFE
Health system	Throughput, labor cost, service line mix, and payer contract yield.	Cost structure, capacity and access, clinical operations, and the consolidation of duplicated functions across sites.	Permanent
Medical group	Revenue cycle performance, scale economics, and physician alignment.	The back office. Billing and collections, patient experience, operational scale, facilities, and the integration of acquired practices.	Permanent
Health plan	Medical loss ratio and administrative expense ratio. Two levers, both enterprise wide.	A value creation plan with a number attached, usually spanning administrative cost, core system modernization, and clinical operating model.	Finite
Third party administrator	Administrative fees. There is no medical margin to manage at all.	The service itself. Transformation is the product being sold, not an internal program, which makes this the least understood version of the role.	Permanent

THE MEDICAL GROUP VERSION IS A BACK OFFICE ROLE

The clearest published example sits at the largest radiology practice in the country, where the Chief Transformation Officer oversees revenue cycle management operations and patient experience, and leads work on operational scale, efficiency, and real estate strategy. That is not a clinical portfolio. It is the margin portfolio, and in a physician owned group at national scale, margin is made in billing, in integration, and in square footage.

The same organization staffs a genuine Transformation Office beneath the role, with senior leaders responsible for running steering committees and governance forums, managing multiple concurrent workstreams with milestone tracking and accountability structures, and supporting negotiations involving physician alignment, funding models, and organizational restructuring. That last item is the tell. An office that touches funding models and organizational structure has real authority. An office that only tracks milestones does not.

The health plan version has a shorter life, and that is the design

The payer side behaves differently from every other setting, and the pattern is visible in the most prominent example the industry has produced.

In January 2022 a large national managed care organization appointed a Chief Transformation Officer to lead a newly created Value Creation Office alongside an operating division. He reported not to the chief executive but to the vice chair of the board. Within months he was added to the office of the chief executive. By December of the same year, eleven months after appointment, he had been named Chief Operating Officer. He subsequently notified the company of his retirement.

Read casually, that looks like a role that failed to last. Read carefully, it looks like a role that worked exactly as intended. A value creation mandate is finite by construction. It has a number, a timeframe, and an end. When the mandate is delivered, the executive either takes over the permanent operating role or leaves. Both are legitimate endings. What is not legitimate is failing to decide which one was intended at the point of appointment.

A permanent function and a finite mandate are both defensible. Confusing the two is what produces an executive with a title and no authority in year three.

Two structural features distinguish the health plan version and both deserve attention from anyone designing the role.

The reporting line is a signal. A transformation executive reporting to the board or to the vice chair carries a different weight than one reporting into operations. The literature is direct on this point: the office needs a mandate to challenge upward as well as downward, including challenging the chief executive when targets slip. A role reporting into the function it must challenge cannot do that.
The finance relationship is the control. On the payer side the benefit is a ratio, and ratios can be argued. Without the finance organization verifying claimed value against the actual profit and loss statement, transformation reporting becomes a collection of initiatives that each saved money while the total never moved.

THE ADMINISTRATOR VERSION NOBODY DISCUSSES

A third party administrator has no medical margin. Its revenue is an administrative fee, usually per member per month, and its cost is almost entirely the cost of administration. That inverts the role completely. In every other setting, transformation is an internal program that improves the organization. In an administrator, transformation is the thing being sold. The buyer is a self funded employer or a health plan purchasing the promise of a lower administrative load.

Which means the administrator’s transformation executive is not primarily an internal change agent. They are closer to a product owner whose product happens to be the operating model itself. Very few organizations in this category have structured the role that way, and it is the largest unclaimed opportunity in this article.

What the role owes, and what it must never absorb

Position descriptions for this role are written as lists of responsibilities, which is why they are interchangeable and why none of them prevents the failure that actually occurs. The useful definition is relational. A transformation office exists in eight working relationships, and in each one it owes something specific and must refuse something specific.

The second column is the one that matters. Transformation offices rarely fail because they were given too little. They fail because they absorbed functions that belonged to someone else, and an office that has absorbed enough of the organization can no longer challenge it.

RELATIONSHIP	WHAT THE ROLE OWES	WHAT IT MUST NEVER ABSORB
The board	A verified position rather than a narrative. The number, the variance against it, what has been stopped, and what is at risk.	The board’s independent line of sight. If this office is the board’s only window into change, the board has no way to test what it is told.
The chief executive	Delivery of the target, and the willingness to say plainly when the chief executive is the constraint.	The chief executive’s authority. An office operating as the enforcer converts every peer into an adversary and forfeits the cooperation the role depends on.
The chief financial officer	Every claimed benefit traced to a baseline, with stated attribution methods and rules preventing the same dollar from being counted twice.	Verification of its own results. The moment the office both claims and confirms value, its reporting is self assessment.
Technology	Sequencing, the business case, and adoption. Technology can deliver a platform. Only this office can deliver the change in how work is done around it.	The platform roadmap and architectural authority. Those belong to the chief information officer, and taking them adds a second full time job the office is not staffed for.
Compliance and risk	Early involvement as a design input rather than late involvement as a constraint. Bring them the design, not the finished implementation.	Compliance itself, or internal audit. A function cannot review work it delivered. This boundary is violated more often than any other on this page.
Procurement	Demand discipline. A defensible statement of what is actually required, so procurement is negotiating for something specific rather than for a category.	The authority to go around it for speed. Nearly every tool that entered an organization unrecorded entered because someone senior judged the process slower than the opportunity.
The line	Realistic sequencing and honest capacity arithmetic. This office is the only party positioned to see the total change load falling on any one team.	Ownership of the result. If the office delivers the change, the line has not changed, and the improvement reverses the quarter after the office moves on.
The workforce	Truth about what is changing and when, and follow through on whatever was committed to people whose roles change.	The assumption that adoption is a communications problem. When people are not using it, the design is usually wrong and the office is usually the last to hear.

TWO CONSEQUENCES WORTH STATING PLAINLY

The finance relationship is the one that determines whether the role is real. Every other line in this table can be negotiated. That one cannot. An office reporting its own results without the chief financial officer confirming they reached the profit and loss statement will produce a portfolio in which every initiative saved money and the total never moved. This is the most common way these offices lose credibility, and it happens in year two.

The compliance boundary is the one most often broken. Compliance and internal audit are regularly attached to transformation because both were assigned to whoever seemed most organized. The result is a function reviewing its own delivery, which produces clean reports and no assurance.

The 2027 agenda

What follows is a projection rather than a survey. It is built from where executive attention sits now and from the structural pressures that will not resolve within a year.

The starting conditions are unambiguous. Cost containment has been the leading priority for payers for consecutive years, with roughly half of health plan executives naming rising costs as their principal challenge. Medical cost trend projections for group and individual coverage have remained near or above eight percent. Among health plans investing in response, the largest share are applying artificial intelligence and analytics to automate manual work and reduce rework, followed by core system modernization and digital engagement. Competitive pressure and growth have risen sharply as a stated concern, particularly among plans serving government programs.

THE FAILURE MODE WITH A NAME

Before the agenda, the warning. Without sustained attention from the chief executive and the chief financial officer, a transformation office reliably degrades into a reporting body. It tracks milestones rather than impact, credibility erodes, and within two years it produces an accurate account of activity that nobody connects to results. This is the most common outcome in the sector and it is not caused by the people in the office. It is caused by the absence of the two relationships in the preceding table that cannot be delegated.

Extend those conditions forward and the 2027 transformation agenda has five items on it. Four of them appear on every forecast published this year, which does not make them wrong. The fifth appears on none of them.

Administrative cost as a strategic target rather than an efficiency exercise. The shift underway is from trimming administrative expense to redesigning the operating model that produces it. That is a different program with a different sponsor, and it cannot be delivered by a cost reduction team.
Converting artificial intelligence pilots into operating results. Most organizations now have deployments. Far fewer can point to a line on the profit and loss statement that moved because of them. The 2027 question is not what have we deployed. It is what did it change, measured by someone who did not sponsor it.
Core platform modernization with the operating model attached. Replacing a core system without redesigning the work around it produces the same processes at higher cost. This is where transformation offices earn their existence or fail visibly.
The payer and provider boundary. This is the one nobody is forecasting. A provider submits a bill. The plan adjudicates it. Authorization, submission, adjudication, denial, and appeal now involve automation on both sides of that exchange, and the volume is rising on both. Cost is accumulating in the space between two organizations rather than inside either one, which means no transformation office is currently measured on it and no single executive owns it. It is the largest unworked opportunity in the sector, and it will be claimed by whoever is willing to build a function that reaches across an organizational boundary rather than optimizing within one.
Workforce transition as a deliverable rather than a consequence. Roles built around tasks that are now automated will change. Organizations that plan that transition will retain capability. Organizations that let it happen will discover what they lost after it is gone.

What the role does not do, and what is missing

Four gaps appear consistently. None of them is a failing of the executives holding the role. Each is a consequence of how the role was scoped when it was created.

ONE. ALMOST NONE OF THEM OWN ARTIFICIAL INTELLIGENCE GOVERNANCE

Transformation executives are frequently the largest single sponsor of artificial intelligence deployment in their organizations and are almost never accountable for governing it. The office is measured on speed of delivery. Speed and governance pull against each other, and when they sit with different people, the person measured on speed wins every quarter.

This gap is large enough to warrant its own treatment. It is the subject of a companion article in this series, Who Owns Artificial Intelligence?, which examines what happens to an artificial intelligence agenda attached to a person rather than a function, and why consortium and shared services arrangements have made the question harder.

TWO. NOBODY OWNS STOPPING

Transformation portfolios accumulate. Initiatives are added, few are formally retired, and the organization ends up carrying the operating cost of every program it has ever begun. A transformation office with no authority to terminate work is not a transformation office. It is an additive function, and additive functions eventually become the thing that needs transforming.

THREE. THE COMPLIANCE AND REGULATORY PERSPECTIVE IS ABSENT FROM THE SEAT

Given that appointments come overwhelmingly from operations and consulting, the transformation office typically has no one who has personally lived through a regulatory examination, a corrective action plan, or an audit finding. Regulatory requirement is therefore treated as a constraint discovered late rather than a design input considered early. The cost of that appears eighteen months after implementation and is charged to a different budget.

FOUR. THE ROLE HAS NO PROFESSIONAL DEFINITION AND NO SUCCESSION PATH

There is no settled position description, no established career ladder into the seat, and no accepted definition of what good looks like in year three. Certification has begun to appear but is new and thin. The practical consequence is that each organization negotiates the role individually, which is why comparing two Chief Transformation Officers tells you almost nothing about either.

An office measured on delivery, sponsoring the fastest moving technology in the sector, with no accountability for its governance and no authority to stop anything, is not a transformation function. It is an acceleration function.

Seven questions that separate a mandate from a title

For a board or a chief executive evaluating whether the role exists in substance or only on the organizational chart.

Is there a number? A transformation mandate without a quantified target and a date is a coordination role. That is a legitimate job. It is not this one.
Who verifies the number? If the transformation office reports its own results without finance confirming they reached the profit and loss statement, the reporting is self assessment.
Can the role challenge upward? Including the chief executive, when the chief executive is the reason a milestone slipped. If not, the office can only challenge people who cannot defend themselves.
Is the mandate permanent or finite? Both work. Not deciding does not, and the decision belongs at appointment rather than at year three.
What has been stopped? A portfolio that has only grown has never been managed. Ask for the list of terminated initiatives and the reasons.
Who owns governance of the technology this office is deploying? If the answer is the same executive who deploys it, independence is missing. If the answer is nobody, the exposure is unowned.
Is compensation tied to delivery? The answer to this question predicts the answers to the other six more reliably than anything else on the list.

A closing observation

Healthcare did not invent the Chief Transformation Officer and it has not yet defined one. What it has done is adopt a title from sectors where transformation meant a finite recovery with a bottom line target, and apply it to organizations where the work is permanent, distributed, and regulated.

The organizations getting it right have done one specific thing. They decided, before appointing anyone, whether they were creating a permanent operating function or a finite mandate, and they wrote down the number attached to it. Everything else in this article follows from that single decision.

The organizations getting it wrong have a capable executive, an ambitious portfolio, a respectable dashboard, and no way to answer the only question that matters, which is what is different now that was not different before.

Sources

Role definition and transformation office structure. McKinsey and Company, The role of the chief transformation officer; The role of the transformation office; What does a chief transformation officer do. World Economic Forum summary of the same work.
Health system appointments. Becker’s Hospital Review, thirty one hospital and health system chief transformation officers to know, 2025; The rise of health system chief transformation officers.
Medical group structure. Radiology Partners published leadership roster and posted position description for Vice President, Strategy and Transformation.
Health plan appointments. Centene Corporation announcements of January 2022 and December 2022; Becker’s Payer Issues; Healthcare Dive; St. Louis Post-Dispatch coverage of subsequent leadership changes. Humana leadership roster and executive appointment announcements.
Payer priorities and cost trend. HealthEdge 2026 Annual Payer Report, based on responses from more than five hundred fifty health plan executives; PwC medical cost trend projections; Becker’s Payer Issues survey of health plan leaders on 2026 priorities.

Organizational details reflect published information available at the time of writing and change frequently. Verify current titles and reporting relationships before relying on any specific reference. Projections regarding 2027 are the author’s analysis and are not attributed to any cited source.

Article 8. Who Owns Artificial Intelligence? The companion article in this series. The Preliminary AI Maturity Assessment. Twelve Questions Every Healthcare Board Should Ask About AI. Redesigning Healthcare: Unfiltered, Episode 5, Medical Groups and AI: Building the Right Foundation. All available at hlthworks.com.

HLTHWORKS builds artificial intelligence governance, scalability, sustainability, oversight, audit readiness, and a mature enterprise solution for medical groups, health systems, health plans, payers, and the vendors, plus investors serving them.